References
- Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol 2010;7:599-610
- Steinmetz T, Totzke U, Schweigert M, et al. A prospective observational study of anaemia management in cancer patients - results from the German Cancer Anaemia Registry. Eur J Cancer Care (Engl) 2011;20:493-502
- Bailie GR, Horl WH, Verhof JJ. Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America. Drug Res 2011;61:267-75
- European Medicines Agency. Reflection paper on non-clinical studies for generic nanoparticle iron medicinal product applications. 2011. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/04/WC500105048.pdf [Last accessed 17 August 2011]
- Schellekens H, Klinger E, Muhlebach S, et al. The therapeutic equivalence of complex drugs. Regul Toxicol Pharmacol 2011;59:176-83
- Rottembourg J, Kadri A, Leonard E, et al. Do two intravenous iron sucrose preparations have the same efficacy? Nephrol Dial Transplant 2011;26:3262-7
- Toblli JE, Cao G, Oliveri L, et al. Differences between original intravenous iron sucrose and iron sucrose similar preparations. Arzneimittelforschung 2009;59:176-90
- Toblli, JE, Cao, G, Giani, J et al. Different effects of European iron sucrose similar preparations and originator iron sucrose on nitrosative stress, apoptosis, oxidative stress, biochemical and inflammatory markers in rats. XLVIII ERA EDTA Congress 2011 [abstract SuO028]
- Medice Arzneimittel Pütter GmbH. Summary of Product Characteristics (Fachinformation), FerMed®, Germany. 2010. http://www.pharmnet-bund.de/dynamic/de/index.html [Last accessed 17 August 2011]
- Vifor France SA. Summary of Product Characteristics (Fachinformation), Venofer®, Germany. 2010. http://www.pharmnet-bund.de/dynamic/de/index.html [Last accessed 17 August 2011]